Utility of Promoter Hypermethylation for Differentiating Malignant and Benign Effusions in Liquid-Based Cytology Specimens
김가언, 김조헌, 김영희, 최찬, 이지신,
소속 상세정보
김가언 ( Kim Ga-Eon )
전남대학교 의과대학 병리학교실
김조헌 ( Kim Jo-Heon )
제주대학교 의학전문대학원 병리학교실
김영희 ( Kim Yeong-Hui )
전남대학교 의과대학 병리학교실
최찬 ( Choi Chan )
전남대학교 의과대학 병리학교실
이지신 ( Lee Ji-Shin )
전남대학교 의과대학 병리학교실
KMID : 0357920100440030315
Abstract
Background: Making the cytologic differentiation between benign and malignant effusions can be difficult. Because promoter hypermethylation of tumor suppressor genes is a frequent epigenetic event in many human cancers, it could serve as a marker for the diagnosis of cancer. The aim of this study was to investigate the feasibility of detecting promoter hypermethylation as a diagnostic tool with using liquid-based cytology samples for differentiating between malignant and benign effusions.
Methods: A multiplex, nested, methylation-specific polymerase chain reaction analysis was used to examine promoter methylation of 4 genes (retinoic acid receptor-β, [RAR-β], adenomatous polyposis coli [APC], Twist and high in normal-1 [HIN-1]) in malignant (n = 85) and benign (n = 31) liquid-based cytology samples.
Results: The frequencies of hypermethylation of RAR-β, APC,Twist and HIN-1 were significantly higher in the malignant effusions than in the benign effusions (p < 0.001 for each). On the receiver-operating characteristic analysis, the area under the curve (AUC) for APC was the greatest. The AUC for the best two-gene combination (APC/HIN-1) was not statistically different from the AUC for the best individual tumor suppressor gene (APC).
Conclusions: This study suggests that promoter methylation analysis on residual liquid-based effusion samples may be a feasible approach to detect malignant effusions, and that APC is the best marker for differentiating between malignant and benign effusions.
키워드
Liquid based cytology;Malignancy;Body fluids;Methylation;Polymerase chain reaction
원문 및 링크아웃 정보
등재저널 정보